2m 2m 2m 2m 2m 2m 2m
SCILEX HLDG CO (SCLX)
NASDAQ
$7.20+$0.03 (+0.42%)
Price as of Jun 03, 2026 7:23 PM EDT- $62.6MMarket Cap
- 2.87%1-Year Change
- Drug Manufacturers - GeneralIndustry
SCILEX HLDG CO (SCLX)
$7.20+$0.03 (+0.42%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 30.3M -46.54% | 56.6M +21.07% | 46.7M +22.90% | 38.0M N/A | |
Cost of Revenue | 10.6M -36.49% | 16.7M +6.43% | 15.7M +45.23% | 10.8M +973.80% | |
Gross Profit | 125.8M +215.28% | 39.9M +28.46% | 31.1M +14.04% | 27.2M +2,808.81% | |
Sales and Marketing Expense | 266.9M +124.24% | 119.0M -0.52% | 119.6M +84.36% | 64.9M N/A | |
Research and Development Expense | -20.7M +114.81% | -9.6M -24.36% | -12.7M +40.78% | -9.1M N/A | |
Depreciation and Amortization Expense | 4.6M +14.26% | 4.0M -2.41% | 4.1M +4.67% | 4.0M N/A | |
Total Operating Expenses | 643.1M +148.32% | 259.0M -4.71% | 271.8M +77.01% | 153.6M +15,172.33% | |
Operating Profit | -346.0M +314.90% | -83.4M -20.90% | -105.4M +108.22% | -50.6M +4,935.71% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -300,000 N/A | N/A N/A | -1.1M -88.88% | -9.6M +525,858.38% | |
Interest Income and Expense and Net | -300,000 N/A | 0 +100.00% | -1.1M -88.88% | -9.6M -33,316.89% | |
Total Nonoperating Income and Expense | -28.0M -364.64% | 10.6M +219.14% | -8.9M -132.58% | 27.3M +1,493,547.32% | |
Income before Taxes | -374.0M +413.72% | -72.8M -36.31% | -114.3M +389.38% | -23.4M +2,223.23% | |
Income Taxes | 26,000 +2,700.00% | -1,000 -107.69% | 13,000 +225.00% | 4,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -374.1M +413.76% | -72.8M -36.32% | -114.3M +389.35% | -23.4M -3,082.24% | |
Net Income from Continuing Operations Applicable to Common | -402.5M +452.81% | -72.8M -36.31% | -114.3M +389.38% | -23.4M -3,081.73% | |
Basic EPS and Net Income | -36.48 +6,414.29% | -0.56 -56.25% | -1.28 +652.94% | -0.17 -440.00% | |
Diluted EPS and Net Income | -36.48 +5,880.33% | -0.61 -52.34% | -1.28 +652.94% | -0.17 -440.00% | |
Basic Weighted Average Shares | 11,034 -99.99% | 131.1M +0.64% | 130.3M +96,973.59% | 134,226 -99.20% | |
Diluted Weighted Average Shares | 11,034 -99.99% | 134.1M +2.90% | 130.3M +96,973.59% | 134,226 -99.20% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.0M +51.44% | 3.3M -16.55% | 3.9M +79.53% | 2.2M +329.99% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 5.0M +51.44% | 3.3M -16.55% | 3.9M +79.53% | 2.2M +169.07% | |
Total Current Assets | 38.4M -7.68% | 41.5M -11.19% | 46.8M +58.00% | 29.6M +5,677.66% | |
Accumulated Depreciation | 321,000 +401.56% | 64,000 +10.34% | 58,000 -65.27% | 167,000 N/A | |
Property and Plant and Equipment and Net | 13.6M +1,820.76% | 708,000 -1.94% | 722,000 -6.48% | 772,000 N/A | |
Total Long-Term Assets | 19.6M +2,671.89% | 708,000 -1.94% | 722,000 -6.48% | 772,000 -99.45% | |
Total Assets | 365.0M +292.65% | 93.0M -8.25% | 101.3M +17.08% | 86.5M -38.16% | |
Income Taxes Payable | 232.8M +16,814.97% | 1.4M -50.00% | 2.8M N/A | N/A N/A | |
Total Short-Term Debt | 83.3M +138.74% | 34.9M -67.84% | 108.4M N/A | 0 N/A | |
Total Current Liabilities | 483.7M +86.28% | 259.6M +3.70% | 250.4M +458.36% | 44.8M +21,385.93% | |
Total Long-Term Debt | 22.5M +2,560.36% | 845,000 -95.04% | 17.0M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 174,000 +12.26% | 155,000 -13.41% | 179,000 +9.82% | 163,000 +2,265.06% | |
Total Liabilities | 576.7M +101.94% | 285.6M +4.14% | 274.2M +445.35% | 50.3M +444.23% | |
Retained Earnings | -921.8M +63.71% | -563.1M +14.85% | -490.2M +30.41% | -375.9M +4,222.12% | |
Total Stockholders Equity | -207.8M +7.86% | -192.6M +11.39% | -172.9M -577.22% | 36.2M +516.68% | |
Total Shares Outstanding | 7.0M -96.16% | 183.2M +83.22% | 100.0M -29.24% | 141.3M +3,997.07% | |
Cash Flow | |||||
Cash from Operating Activities | 3.8M -80.28% | 19.3M +193.44% | -20.7M -2.59% | -21.3M +2,552.84% | |
Capital Expenditures | 133,000 N/A | 0 -100.00% | 30,000 +328.57% | 7,000 N/A | |
Cash from Investing Activities | 4.1M +252.67% | -2.7M +710.61% | -330,000 -84.03% | -2.1M -98.52% | |
Dividends Paid | N/A N/A | 8.7M 0.00% | 8.7M N/A | N/A N/A | |
Cash from Financing Activities | -5.5M -69.88% | -18.1M -176.88% | 23.6M +11.39% | 21.2M -84.95% | |
Financials Ratio | |||||
Gross Margin | 64.97% -7.86% | 70.51% +6.10% | 66.45% -7.20% | 71.61% N/A | |
Operating Margin | -1,143.71% +676.09% | -147.37% -34.66% | -225.55% +69.43% | -133.13% N/A | |
Return on Assets | -163.37% +117.94% | -74.96% -38.43% | -121.73% +489.94% | -20.63% -1,945.38% | |
Return on Equity | 186.83% +369.05% | 39.83% -76.19% | 167.27% +198.59% | -169.66% +839.70% | |
Revenue Growth | -46.54% -320.92% | 21.07% -8.00% | 22.90% N/A | N/A N/A | |
Current Ratio | 0.08 -50.44% | 0.16 -14.35% | 0.19 -71.71% | 0.66 -73.11% | |
Cash Ratio | 0.01 -19.05% | 0.01 -19.75% | 0.02 -67.76% | 0.05 -98.00% | |
Debt-to-Equity Ratio | -0.51 +174.49% | -0.19 -74.45% | -0.73 N/A | 0.00 N/A | |
Debt-to-Assets Ratio | 0.29 -24.62% | 0.38 -68.97% | 1.24 N/A | 0.00 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow